— Know what they know.
Not Investment Advice

BMNDF OTC

Biomind Labs Inc.
1W: +83.8% 1M: +83.8% 3M: +283.3% YTD: +303.5% 1Y: +2811.4% 3Y: -53.5%
$0.46
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Buy · Power 63 · $35.7M mcap · 49M float · 0.012% daily turnover · Short 88% of daily vol

Cash Flow Trends

Operating Cash Flow
-$354K +53.7% ▲
Capital Expenditures
$0 +0.0% ▲
Free Cash Flow
-$354K +53.7% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$24K -1175.4% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$190K-$4M-$3M-$1M-$260K
Depreciation & Amort.$0$28K$44K$15K$9K
Stock-Based Comp.$0$1M$554K$8K$0
Change in Working Capital$40K-$104K$186K$229K$47K
Other Non-Cash Items$0$840K$1K$196K-$150K
Operating Cash Flow-$150K-$2M-$2M-$766K-$354K
— Investing Activities —
Capital Expenditures$0-$45K$0$0$0
Acquisitions (Net)$0$250$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0$0
Investing Cash Flow$0-$44K$0$0$0
— Financing Activities —
Net Debt Issuance$0-$30K-$39K$785K$307K
Stock Repurchased$0$0$0$0$0
Dividends Paid-$108K$0$0$0$0
Other Financing$0$0$0-$22K-$245
Financing Cash Flow-$108K$4M-$39K$762K$302K
Net Change in Cash-$252K$2M-$2M-$2K-$24K
Cash End of Period$82K$2M$26K$24K$147
Free Cash Flow-$150K-$2M-$2M-$766K-$354K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms